---
figid: PMC3362997__nihms377186f10
figtitle: Competitive displacement of DMP1 by ASARM peptide modulates PHEX–DMP1-mediated
  FGF23 expression (see central osteoblast in green)
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Canis lupus familiaris
- Sus scrofa
- Elephas maximus
- Vicugna pacos
- Tupaia glis
- Delphinus delphis
- Macropus sp.
- Procavia capensis
- Vicugna vicugna
- Homo sapiens
- Macaca mulatta
- Pan troglodytes
- Callithrix jacchus
- Hylobates sp.
- Pongo pygmaeus
- Mus musculus
- Rattus norvegicus
- Dipodomys californicus
- Dinosauria
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Pan troglodytes
- Canis lupus familiaris
- Vicugna pacos
- Sus scrofa
- Oryctolagus cuniculus
- Callithrix jacchus
- Pongo pygmaeus
- Macaca mulatta
- Bos taurus
- Drosophila melanogaster
- Arabidopsis thaliana
pmcid: PMC3362997
filename: nihms377186f10.jpg
figlink: /pmc/articles/PMC3362997/figure/F10/
number: F10
caption: 'Competitive displacement of DMP1 by ASARM peptide modulates PHEX–DMP1-mediated
  FGF23 expression (see central osteoblast in green). Specifically, DMP1 and PHEX
  interact and signal a down regulation of FGF23 as discussed in the text. ASARM disrupts
  this binding (PHEX + DMP1), resulting in an up-regulation of FGF23 signaling as
  discussed in . This in turn leads to major changes in bone mineralization, bone
  turnover, vitamin D metabolism with hypophosphatemia. Recent evidence indicates
  that this also impacts fat energy metabolism pathways as depicted in the scheme
  and discussed in the text. Profound changes in fat mass, weight, glucose metabolism,
  insulin sensitivity, leptin levels, serotonin levels, sympathetic tone, aldosterone
  levels, vascularization, and sympathetic tone, occur in mice with defects in PHEX,
  DMP1, FGF23, MEPE, and ASARM expression. ,,,–,,,,– Index: SNS, sympathetic nervous
  system; Adrβ2, Osteoblast β2 adrenergic receptors (responsive to epinephrine/norepinephrine);
  Gla-OCN, γ-carboxylated osteocalcin (inactive form); Unc-OCN, γ-de-carboxylated
  osteocalcin (active form); Esp, Gene for OST-PTP (tyrosine phosphatase) that phosphorylates
  and inactivates the insulin receptor. This directly/indirectly results in reduced
  active osteocalcin (reduced γ-decarboxylation); Tcirg1, Osteoclast proton (H+) pump.
  Increases resorption lacuna acidity (acidic ASARM-peptides likely contribute) and
  thereby increases active osteocalcin (Unc-OCN) by acidic γ-decarboxylation; ASARM,
  Acidic Serine Aspartate Rich MEPE associated peptide or motif.'
papertitle: 'Regulation of Bone–Renal Mineral and Energy Metabolism: The PHEX, FGF23,
  DMP1, MEPE ASARM Pathway.'
reftext: Peter S. N. Rowe. Crit Rev Eukaryot Gene Expr. ;22(1):61-86.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9704825
figid_alias: PMC3362997__F10
figtype: Figure
redirect_from: /figures/PMC3362997__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3362997__nihms377186f10.html
  '@type': Dataset
  description: 'Competitive displacement of DMP1 by ASARM peptide modulates PHEX–DMP1-mediated
    FGF23 expression (see central osteoblast in green). Specifically, DMP1 and PHEX
    interact and signal a down regulation of FGF23 as discussed in the text. ASARM
    disrupts this binding (PHEX + DMP1), resulting in an up-regulation of FGF23 signaling
    as discussed in . This in turn leads to major changes in bone mineralization,
    bone turnover, vitamin D metabolism with hypophosphatemia. Recent evidence indicates
    that this also impacts fat energy metabolism pathways as depicted in the scheme
    and discussed in the text. Profound changes in fat mass, weight, glucose metabolism,
    insulin sensitivity, leptin levels, serotonin levels, sympathetic tone, aldosterone
    levels, vascularization, and sympathetic tone, occur in mice with defects in PHEX,
    DMP1, FGF23, MEPE, and ASARM expression. ,,,–,,,,– Index: SNS, sympathetic nervous
    system; Adrβ2, Osteoblast β2 adrenergic receptors (responsive to epinephrine/norepinephrine);
    Gla-OCN, γ-carboxylated osteocalcin (inactive form); Unc-OCN, γ-de-carboxylated
    osteocalcin (active form); Esp, Gene for OST-PTP (tyrosine phosphatase) that phosphorylates
    and inactivates the insulin receptor. This directly/indirectly results in reduced
    active osteocalcin (reduced γ-decarboxylation); Tcirg1, Osteoclast proton (H+)
    pump. Increases resorption lacuna acidity (acidic ASARM-peptides likely contribute)
    and thereby increases active osteocalcin (Unc-OCN) by acidic γ-decarboxylation;
    ASARM, Acidic Serine Aspartate Rich MEPE associated peptide or motif.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SCN10A
  - PTPRVP
  - SPESP1
  - BTF3P11
  - TNFRSF11B
  - FGF23
  - DMP1
  - DMTF1
  - PHEX
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - TCIRG1
  - MEPE
  - Scn10a
  - Ptprv
  - Tnfrsf11b
  - Fgf23
  - Dmp1
  - Dmtf1
  - Phex
  - Tcirg1
  - Mepe
  - sns
  - Esp
  - Lamtor3
  - ww
  - ESP
  - WRR4
  - Glucose
---
